chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Large red rash with itching .  Began below injection site, moved above injection site and after 6 days, moved below injection site  At largest 6 x 4 inches,  Applialsoed hydrocortisone cream twice a day.  Tender to touch
received a Moderna COVID-19 vaccine Booster dose after 12 hours post punctured; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received a Moderna COVID-19 vaccine Booster dose after 12 hours post punctured) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 083J21A) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.    On 12-Mar-2022 at 1:30 PM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 12-Mar-2022 at 1:30 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (received a Moderna COVID-19 vaccine Booster dose after 12 hours post punctured). At the time of the report, EXPIRED PRODUCT ADMINISTERED (received a Moderna COVID-19 vaccine Booster dose after 12 hours post punctured) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The reporter did not know if the patient had any allergies or tested positive for COVID-19 or received any other vaccine within 1 month prior to Moderna. The reporter did not know if the patient had any acute or chronic illnesses.  The reporter did not know if the patient was taking any concomitant medication.  The reporter did not have any information about the first 3 doses or manufacturer of the COVID-19 vaccine for the patient.  The vial was initially stored in the refrigerator was on 09-Mar-2022. The vial was first punctured on 11-Mar-2022 on 15:13 pm. The vial was stored in room temperature post puncture and the vial did not undergo any temperature excursions. Total amount of time the vial was exposed to room temperature range (8 degree to 25 degree Celsius = 46 degree to 77-degree Fahrenheit) was 22 hours. The reporter confirmed that the patient received the booster dose in her deltoid muscle and also the reporter did not know if the patient was experiencing any symptoms.  No treatment information was provided by the reporter.   This case was linked to MOD-2022-512464 (Patient Link).
Case felt weak and fatigued. Went to hospital and tested positive for Covid-19. Hospitalization at Medical Center was 7/22/21 through 8/2/21. Case did not know if Covid-19 was primary reason for hospitalization. His diabetes was stabilized, and he was treated for low blood pressure.
I had developed a sore throat, headache, and muscle aches for some days. I took an at-home COVID-19 test on 12/04/2022 when my symptoms wouldn't go away to see if I had possibly contracted COVID-19; unfortunately the test came back positive. I contacted my doctor the next morning and informed her I contracted the virus and later was prescribed PAXLOVID. I took the prescription, and within days, I recovered well. Since then, I caught a cold that's finally settled, but I'm doing much better and well now.
Fever of 99.5; muscle aches; joint aches; cold sweat; This is a spontaneous report received from a contactable consumer or other non hcp. A 73-years-old male patient received 1st dose of bnt162b2 (COMIRNATY,Batch/Lot Number: EN6202), via an unspecified route of administration, administered in Arm Left on 27Feb2021 10:30,at the age of 73 years old, as Dose 1,single for covid-19 immunization .The patient medical history was not reported. Concomitant medications included clindamycin,celecoxib taken for arthritis and lisinopril taken for an unspecified indication, start and stop date were not reported.The patient previously took penicillin b and experienced drug hypersensitivity.The patient experienced fever of 99.5, muscle aches, joint aches and cold sweat on 27Feb2021 21:00.The outcome of the events was recovered.The drug was administered at pharmacy or drug store.The patient had not received any other vaccine within 4 weeks.The patient had not received any treatment for the event.The patient was not diagnosed with covid prior vaccination and not tested for covid post vaccination.The adverse event didn't result in patient emergency room and physician office visit.  No follow-up attempts are possible. No further information is expected.
In September 2015, my son started having significant sleep issues which progressed and got worse as time went on. It got to the point he physically COULD NOT fall asleep. During the transition from "awake" to "sleep" he started to have severe epileptic episodes.  The epileptic episodes would go on all night from approx 11p until approx 6a. ONLY occuring when his brain started to wander off to sleep. He got to the point where he couldnt even get 4 solid hours of sleep in a night. I of course brought him to his pediatrician. They had zero answers in anyway shape or form and referred us to a pediatric neurologist who also determined there was "nothing" wrong w/ my son. We were also referred to an ENT Dr who referred us for a sleep study.  This went on for approx 10mos, at which point I realized none of the drs were able to give me any explanantion what so ever. I started researching my sons symptoms. Nothing seemed to fit. The only thread of info I could find where the exact symptoms of my son matched was in a forum that different moms had written in. They also had been left in the dark and had no answer about what was happening to their kids. Upon relentless research, I ordered lavender,vetiver, and cedarwood essential oils. I applied at night before bed and for THE FIRST time in almost a year my sons epuleptic episodes went from a 10, to about a 4. At that point I cancelled all appointments related to his condition bc I was better able to treat my son then any of the Drs had been able to.
felt paralyzed and nauseous; felt paralyzed and nauseous; fever; This is a spontaneous report from a contactable consumer. A 78-years-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) (at the age of 78-years-old) as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19 via antibodies test on an unspecified date with positive result. On an unspecified date, a day after receiving the vaccine, the patient developed a fever and said that she felt paralyzed and nauseous. The patient needed to go to the hospital in order to recover and tested positive for antibodies. The outcome of events, fever, felt paralyzed and nauseous was unknown.   The lot number for the vaccine, BNT162b2, was not provided and will be requested during follow up.
On day 9 my arm started to itch and swell at the injection site. Redness surrounds the site. Feels warm to touch and tender.  Today is the first day of the irritation.
Systemic: Confusion-Severe, Additional Details: Although date of ADR is several days from vaccination this occurred with 3 people at the same facility.
19 cm area of erythema with 40 cm area of induration.  Allodynia in entire upper arm.
This spontaneous report as received from a pharmacist refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with ZOSTAVAX (doses, route and site of administration, lot# and expiration date were not reported). It was reported that an unspecified number of patients developed redness at the injection site following the administration of ZOSTAVAX. The outcome of the events was unknown. The relatedness between the events and ZOSTAVAX was not reported. Additional information has been requested.
Pt recv vax on 12/14/98; on 12/15/98 pt exp lt facial neuralgia. Medical record on 05/05/04 states: diagnoses of cervical and lumbar degenerative disc disease, Bell's Palsy, and fibromyalgia. - UPDATE 08/04/2005 Received a fax from the patient requesting help with a 'vaccine petition' because of her memory problems. UPDATE 10/17/05 Received letter from the patient asking for a note to be placed in her VAERS record about the fact that the vaccine contained mercury. Headaches and now nerve damage to the left side of my face.  Pu on TEGNETOL in March of 00.  Now on one TEGNETOL.
I have had hot flashes two days after my vaccination.; I have them every night since and have not been sleeping well due to them; This is a spontaneous report from a contactable nurse (patient). A 42-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL1284 and expiration date not provided), via an unspecified route of administration (right arm) first dose on 05Jan2021 15:30 at single dose for covid-19 immunisation. The patient's medical history included Known allergies: PCN, latex, eggs. The patient was not pregnant at time of vaccination. There were no concomitant medications. On 07Jan2021 22:00, the patient has had hot flashes two days after vaccination. The patient has never had hot flashes before. The patient have them every night since and have not been sleeping well due to them. The patient did not received treatment for the events.  The outcome of the events was not recovered.
I just do not feel myself; Tired/Fatigue; Joint pain; A little nauseous; Muscle pain; This is a spontaneous report from a contactable Nurse.  This 57-year-old female Nurse reported for herself that she received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 26Dec2020 at single dose for COVID-19 immunisation at the age of 57-year-old. Lot number was EK5730. The patient had not medical history. Concomitant medications were none. Patient received suspect vaccine on 26Dec2020, and she was feeling like really tired, fatigue, joint pain, a little nauseous on 27Dec2020. She did not think she had a fever, but she just did not feel herself. She had like muscle pain on 27Dec2020. She knew that all these are side effects, but she should go and have herself tested (as reported). Maybe the patient was becoming sick and she did not know. The outcome of the events was unknown. Nurse stated about causality that she did think so; she was not feeling sick before; she meant that she was not feeling like this before.
ONE WEEK AFTER COVID VACCINE GIVEN, PATIENT DEVELOPED TWO 1 CM RUBBERY NON TENDER LEFT SIDED SUPRACLAVICULAR LYMPH NODES.
Charge nurse note: @ 2120, LNA reported resident "wasn't right", stated resident was noted to be "flailing his arms". Upon entry into the room resident was found to be unresponsive to sternal rub, labored breathing with RR of 28, blood trickling from the corner of his mouth. Initial VS: 97.9, 112, 28, 240/80, 97% RA. 2 L of O2 was applied as supportive measure. No convulsions noted with this RN's assessment. Supervisor called to floor. Resident a full code--EMS was activated. Within 5 minutes resident's RR came down to 20, nonlabored, making eye contact when his name is called. F/u b/p 180/80. Upon EMS arrival resident was speaking in short sentences when questioned. Resident out to ED @ 2140. Nurse to nurse report given to RN at ED. Nsg. Supervisor note: Called by charge nurse to see resident, LNA reported she heard resident thrashing loudly and that she thought there was someone else in the room with the resident. She stated he was "flailing his arms up here" as she demonstrated what she had observed. Upon entry into the room resident was found to be unresponsive, glazed stare, no response to verbal prompts, labored respirations of 24 on oxygen via face mask, LNA states blood came out of his mouth, repositioned on left side. Resident is a full code and EMS was activated. Upon EMS arrival resident more responsive and responded "hi" with no further further flailing noted. NP notified and resident out to ED @ 2140 with paperwork provided to the EMS staff.
It was reported that a 32 year old female pt was vaccinated with a 0.5ml of Fluzone (U0930FA) IM in the deltoid on 10/29/02. The pt developed a fluid filled blister that drained spontaneously 2 days later. The pt was seen at a walk in clinic and was given an antibiotic cream. A couple of days later, she went to see her private physician, who diagnosed the reaction as "cell death." She was prescribed an oral antibiotic and compresses. According to the physician at the health clinic on 11/4/02, the pt developed mild induration, inflammation, ecchymosis and epidermis sloughing. A scab and an area of indentation are still present. The pt was also seen by a dermatologist.
Racing heart (160 BPM), sores in mouth, confusion, high fever (104F +), vomiting, and most concerning:  I couldn't not figure out how to use my hands.  I could move them, but not where I wanted to.  For example, I couldn't 'find' my face or get my right hand to make contact with my left hand.
Not feeling well; Headaches; Dizzy; Big bruises on my body; Very low blood platelets count; This is a spontaneous report from a contactable consumer (Patient). A 40-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: Unknown), via an unspecified route of administration on 30Mar2021 at 17:45 (at the age of 40-year-old), as dose 1, single; and received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: Unknown), via an unspecified route of administration on 20Apr2021 at 17:45 (at the age of 40-year-old), as dose 2, single for COVID-19 immunization at Pharmacy or Drug Store. The patient's medical history and concomitant medications were not reported. Patient did not receive other vaccine in four weeks of COVID vaccine. On 01Apr2021, after receiving the vaccine, the patient was not feeling well, had headaches, and felt dizzy; had big bruises on her body. Doctor did blood test and it showed very low blood platelets count. Patient believed it was related to vaccine as she didn't experience these problems before. Patient's blood platelets count was normal before that. Adverse events resulted in doctor or other healthcare professional office/clinic visit. Patient did not receive treatment for the adverse events. The patient underwent lab tests and procedures which included SARS-CoV-2 test: unknown result post vaccination on an unspecified date; platelet count: normal before vaccination on an unspecified date; and very low after vaccination on 01Apr2021. The patient had no COVID prior vaccination and was tested COVID post vaccination. The clinical outcome of all the events was not resolved.  Information about lot/batch has been requested.
This case was reported by a consumer and described the occurrence of headache in a male patient who received RABAVERT (batch number 584011A, expiry date unknown). This case was assessed with a product complaint. In March 2016, the patient received RABAVERT. In March 2016, less than a month after receiving RABAVERT, the patient experienced headache and numbness of head. On an unknown date, the patient experienced pharmaceutical product complaint. On an unknown date, the outcome of the headache, numbness of head and pharmaceutical product complaint were unknown. It was unknown if the reporter considered the headache and numbness of head to be related to RABAVERT. Additional details were provided as follows: The age at vaccination was not reported. The patient had a question regarding the RABAVERT Packaging, he received the Rabies vaccine a week or so back and noticed the packaging stated Rabies and not Rabies vaccine. For some reason, probably the magnitude of Rabies, this had bothered him and would like to confirm this for peace of mind. The healthcare nurse was contacted who confirmed that the patient received RABAVERT vaccine and she had provided him with lot number of product and also sent him packaging. She was not sure where they order the vaccine from but she would get with her supervisor to get that information and would call back. She stated that the patient had called there many times concerned about this vaccination and he was a very anxious customer. The patient told them that he was comparing the packaging to packaging of another rabies vaccination that he received years ago. The nurse called back and provided the contact details of the practice pharmacy to find out where they order this vaccine from. The pharmacist was contacted who provided that the details were the vaccine was ordered. She said that none of the RABAVERT cartons said Rabies only, nor they had an image of a bat on any of the packaging. She stated that they do order one other rabies vaccine, Rabies Immune Globulin that goes by the name HyperRAB and also this vaccine do not say Rabies only on the carton and there is no image of a bat on this vaccine either. She stated she was not sure what the patient was looking at.
ACUTE NON ST ELEVATION MI 4/12/2023 LEFT KNEE JOINT PAIN BACTERIAL ARTHRITIS OF LEFT KNEE ACUTE NON ST ELEVATION MI 4/12/2023 ACUTE NON ST ELEVATION MI
Approximately 30 hours of sharp chest pain when taking a deep breath or twisting torso from 3am on 4/13  till 8am on 4/14.    Period delayed 6 days, starting on 4/21 when it should have started 4/16.  This was 34 days between cycles and an irregular occurance.
Site swollen & hot to touch 5 x 3 cm. Grow next day to 10 x 9 cm. Over weekend took prednisone, BENADRYL to relieve symptoms. Ok w/flu shot. Only PNC, ASA, CIPRO allergy.
Few vesicles on R shoulder where vaccine was given. Pt was unaware when reaction started.
Headache, Nausea, dizziness, chilling, tiredness, shortness of breath, complained of chest plain, severe cramps.  9/14/09 Received vaccine & PCP medical records which reveal patient seen 12/5/07 & 2/27/08 with sore throat, fever, chills, fatigue, body aches, productive cough w/yellow sputum & HA.  Dx both times w/acute bronchitis & tx w/antibiotics & cough syrup.  9/25/09 Autopsy report received DOD 09/12/2008. Acute Cardiac Arrhythmia of Unknown Etiology. Addtional information abstracted: Heart with focal microscopic ischemic changes, pulmonary congestion and edema. Rare petechiae: conjunctival, periorbital and laryngeal. Resuscitation related sternal fracture.
SYMPTOMS BEGAN ONE DAY AFTER VACCINE WAS GIVEN. CLIENT RETURNED TO HEALTH DEPARTMENT TWO DAYS AFTER VACCINE WAS ADMINISTERED. THE BACK OF THE LEFT ARM WAS RED, SWOLLEN AND WARM TO TOUCH. THE AREA EXTENDED ABOVE AND BELOW THE INJECTION SITE AND COVERED A LARGE PORTION OF THE ARM. THE CENTER OF THE REDNESS WAS QUARTER SIZED WITH DRIED DRAINAGE PRESENT. TEMP WS TAKEN AND WAS 99F. INSTRUCTED BY NURSES TO SEEK FOLLOW UP WITH PHYSICIAN.
TIGHT CHEST, MUSCLE ACHES HEADACHE 3 DAYS AFTER INJECTION  10/18/2010  THEN TIRED, HEADACHE, MUSCLE /BONE PAIN DIARRHEA CHILLS  ***TOOK THIS IN THE 70'S BECAME  EXTREMELY ILL  ARTHRITIS SYMPTOMS COULD NOT GRIP A HAIRBRUSH OR TURN OVER IN BED WITHOUT EXTREME PAIN
Information has been received from a consumer and a Registered Pharmacist (R.Ph) concerning a 77 year old male patient with a history of "Dental implantation" on 05-JAN-2009 and penicillin allergy, who on 26-JAN-2009 was vaccinated with a 0.65 ml dose of ZOSTAVAX (Merck) (Lot # 663175/1553X) subcutaneously. Concomitant therapy included simvastatin (manufacturer unknown), lisinopril (manufacturer unknown) and vitamins (unspecified). It was reported that on "middle of February 2009" approximately 15-FEB-2009 the patient developed a case of shingles. It was reported that they looked like they were "red spots" on his forehead and on his lower arm between his elbow and his hand. It seemed as if they were getting better however they never cleared up. It was reported that the "red spots" got worse especially with the itching. It was reported that the patient was experiencing a rash on both arms. The patient saw a dermatologist on 14-APR-2009 and was diagnosed with shingles. There were no laboratory diagnostic tests performed. It was reported that the patient had not recovered at the time of the report. Additional information has been requested.
Information has been received from a registered nurse (RN) concerning a 22-week-old male who on 05-JUL-2006 was vaccinated by mouth with the first 2.0 ml dose or rotavirus G1 G2 G3 G4 P1 reassortant vaccine live (human-bovine) (Lot#653915/0389F).  It was unknown if medical attention was sought and no adverse events were reported.  Additional information has been requested. This is in follow-up to report (s) previously submitted on 9/8/2006.  Information has been received from a licensed practical nurse (LPN) concerning a 22-week old white male with no medical history who on 05-JUL-2006 was vaccinated PO with the first 2.0 mL dose of ROTATEQ (Lot #653915/0389F).  Concomitant vaccinations administered on the same day included the second IM dose in the left thigh of PEDIARIX (Lot #AC21B065AA), the second IM dose in the right thigh of ACTHIB (Lot #UE793AA) and the second dose in the right thigh of PREVNAR (Lot #B08658C).  Medical attention was not sought and no adverse events were reported.  Additional information is not expected.
12APR98 8PM T101.4-103.5 rx w/motrin;13APR red blotches on body that faded when temp dec;vomited x 2 when temp inc;14APR inc temp pimple-like dots;rt side neck below jaw started to swell;poss muscle cramps;itching;
received the first dose of SHINGRIX intramuscularly on 31-Dec-2019 / have not received the 2nd dose; may have been COVID-19 or Influenza; upper respiratory tract symptoms; Reporter thinks it may have beed COVID-19 or influenza.; This case was reported by a nurse via call center representative and described the occurrence of covid-19 in a 68-year-old male patient who received Herpes zoster SHINGRIX for prophylaxis.   Co-suspect products included Herpes zoster (SHINGRIX) for prophylaxis.   On 31st December 2019, the patient received the 1st dose of SHINGRIX (intramuscular). On an unknown date, the patient received the 2nd dose of SHINGRIX. In January 2020, less than a month after receiving SHINGRIX and not applicable after receiving SHINGRIX, the patient experienced covid-19 (serious criteria GSK medically significant), upper respiratory symptom and influenza. On an unknown date, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the covid-19, upper respiratory symptom and influenza were recovered/resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the covid-19, upper respiratory symptom and influenza to be related to SHINGRIX.  Additional details were provided as follows: The reporter was patient's wife and also a nurse. The age at vaccination was not applicable for the 2nd suspect vaccine. The patient experienced upper respiratory tract symptoms after SHINGRIX in January and the beginning of February 2020 and reporter thought that it might had COVID-19 or influenza.  The patient did not receive 2nd dose till the time of reporting, which led to incomplete course of vaccination. The reporter did not had the lot numbers for the vaccines but provided the pharmacy's phone number where the shot was administered. The reporter consented to follow-up. This case had been linked with US2020206899, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020206899:same reporter
Pt reported developing a shingles-like rash on her lower left leg beginning 3 days after her vaccination on 6/15/18. Pt described the rash as having a burning sensation and being very painful to the touch. The rash periodically forms vesicles and drains fluid. The rash has been progressing and now wraps around her lower left leg (near the ankle).
Probable sz (unresponsive episodes w/altered tone, no color change) started 2AUG91 (2 episodes) & 4 episodes since lasting 10 min - 30 min associated w/t100-102
Four days after the shot, I developed an itchy hive around the injection site, approximately 2 inches in diameter.